Altos Labs

Biotechs have faced challenges in the last couple years on many aspects: achieving clinical and regulatory milestones, appeasing investors whom are less willing to take risks on early-stage assets, an

The founding of Altos Labs in January 2022, which launched with a record $3bn in venture capital funding from high-profile backers that reportedly include Amazon founder Jeff Bezos and billionaire e

In Vivo's editors, along with experts from the Informa Pharma Intelligence team, selected five top picks for the most significant M&A, alliance and financing deals of 2022. The votes have been counted

John Reed is leaving a mixed legacy after almost five years as head of R&D at Sanofi, a time when the company has struggled to propel products into the market to reduce its reliance on the megablockbu